Further Progress for Patients with Breast Cancer
Daniel F. Hayes
U-M Rogel Cancer Center
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Substantial progress has been made over the past 50 years in the evaluation and treatment of patients with breast cancer, leading to a nearly 40% decrease in mortality from this disease and associated reductions in complications of treatment.1 This progress has occurred with the understanding that breast cancer is not one but several diseases with biologically driven subtypes.2 Each of these subtypes is amenable to different treatment strategies, so that a personalized-medicine approach is possible in the treatment of patients with breast cancer. For example, endocrine treatment in women with estrogen-receptor–positive, but not estrogen-receptor–negative, breast cancer has led to considerable . . .
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies · HER2/EGFR in Cancer Research